These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 19826038

  • 41. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.
    Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S.
    Cancer Res; 2008 Aug 15; 68(16):6533-40. PubMed ID: 18701476
    [Abstract] [Full Text] [Related]

  • 42. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL.
    Cancer Res; 2006 Dec 01; 66(23):11279-86. PubMed ID: 17145873
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
    Qian DZ, Wei YF, Wang X, Kato Y, Cheng L, Pili R.
    Prostate; 2007 Aug 01; 67(11):1182-93. PubMed ID: 17520666
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer.
    Liu M, Howes A, Lesperance J, Stallcup WB, Hauser CA, Kadoya K, Oshima RG, Abraham RT.
    Cancer Res; 2005 Jun 15; 65(12):5325-36. PubMed ID: 15958580
    [Abstract] [Full Text] [Related]

  • 48. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
    Grøvdal LM, Kim J, Holst MR, Knudsen SL, Grandal MV, van Deurs B.
    Cell Signal; 2012 Jan 15; 24(1):296-301. PubMed ID: 21951604
    [Abstract] [Full Text] [Related]

  • 49. Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer.
    Marx C, Yau C, Banwait S, Zhou Y, Scott GK, Hann B, Park JW, Benz CC.
    Mol Pharmacol; 2007 Jun 15; 71(6):1525-34. PubMed ID: 17392524
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.
    Shimizu H, Seiki T, Asada M, Yoshimatsu K, Koyama N.
    Oncogene; 2003 Feb 13; 22(6):831-9. PubMed ID: 12584562
    [Abstract] [Full Text] [Related]

  • 53. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q, Hu S, Gao H, Ma R, Yang Q, Pan Z, Wang T, Li F.
    Oncology; 2008 Feb 13; 75(3-4):159-68. PubMed ID: 18827493
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies.
    Yu D, Hung MC.
    Oncogene; 2000 Dec 11; 19(53):6115-21. PubMed ID: 11156524
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
    Hoeflich KP, O'Brien C, Boyd Z, Cavet G, Guerrero S, Jung K, Januario T, Savage H, Punnoose E, Truong T, Zhou W, Berry L, Murray L, Amler L, Belvin M, Friedman LS, Lackner MR.
    Clin Cancer Res; 2009 Jul 15; 15(14):4649-64. PubMed ID: 19567590
    [Abstract] [Full Text] [Related]

  • 59. Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells.
    Nakamura C, Matsushita I, Kosaka E, Kondo T, Kimura T.
    Rheumatology (Oxford); 2008 Apr 15; 47(4):418-24. PubMed ID: 18281366
    [Abstract] [Full Text] [Related]

  • 60. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G, Zhu B, Rosa F, Deblon N, Adélaïde J, Kahn-Perlès B, Birnbaum D, Imbert J.
    Mol Cancer Res; 2009 Mar 15; 7(3):402-14. PubMed ID: 19276186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.